MEDIX vs. DBLEX

Last updated Jun 4, 2026

MEDIX (MFS Emerging Markets Debt Fund) and DBLEX (DoubleLine Emerging Markets Fixed Income Fund) are both Emerging Markets Bonds funds. Over the past 10 years, MEDIX returned 3.73%/yr vs 3.86%/yr for DBLEX. A 0.69 correlation means they provide meaningful diversification when combined. MEDIX charges 0.81%/yr vs 0.90%/yr for DBLEX.

Performance

MEDIX vs. DBLEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MFS Emerging Markets Debt Fund (MEDIX) and DoubleLine Emerging Markets Fixed Income Fund (DBLEX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, MEDIX achieves a 2.46% return, which is significantly higher than DBLEX's 1.39% return. Both investments have delivered pretty close results over the past 10 years, with MEDIX having a 3.73% annualized return and DBLEX not far ahead at 3.86%.

MEDIX

• 1D: 0.16%
• 1M: 1.09%
• YTD: 2.46%
• 6M: 3.09%
• 1Y: 12.40%
• 3Y*: 9.48%
• 5Y*: 2.13%
• 10Y*: 3.73%

DBLEX

• 1D: 0.11%
• 1M: 0.36%
• YTD: 1.39%
• 6M: 1.64%
• 1Y: 6.51%
• 3Y*: 8.33%
• 5Y*: 2.18%
• 10Y*: 3.86%

*Multi-year figures are annualized to reflect compound growth (CAGR)

MEDIX vs. DBLEX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MEDIX MFS Emerging Markets Debt Fund	2.46%	12.48%	5.92%	9.42%	-15.97%	-2.40%	8.01%	14.12%	-4.99%	9.64%
DBLEX DoubleLine Emerging Markets Fixed Income Fund	1.39%	8.39%	8.20%	9.64%	-15.30%	1.97%	4.85%	11.80%	-3.20%	8.48%

Correlation

The correlation between MEDIX and DBLEX is 0.65, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.65
Correlation (3Y) Calculated over the trailing 3-year period	0.73
Correlation (5Y) Calculated over the trailing 5-year period	0.77
Correlation (10Y) Calculated over the trailing 10-year period	0.71
Correlation (All Time) Calculated using the full available price history since Apr 7, 2010	0.69

The correlation between MEDIX and DBLEX shifts across timeframes, from 0.65 (1 year) to 0.77 (5 years), reflecting how their relationship changes across market environments.

Return for Risk

MEDIX vs. DBLEX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDIX

MEDIX Risk / Return Rank: 84
MEDIX Sharpe Ratio Rank: 94
MEDIX Sortino Ratio Rank: 96
MEDIX Omega Ratio Rank: 93
MEDIX Calmar Ratio Rank: 65
MEDIX Martin Ratio Rank: 70

DBLEX

DBLEX Risk / Return Rank: 89
DBLEX Sharpe Ratio Rank: 94
DBLEX Sortino Ratio Rank: 94
DBLEX Omega Ratio Rank: 95
DBLEX Calmar Ratio Rank: 80
DBLEX Martin Ratio Rank: 80

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MEDIX vs. DBLEX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MFS Emerging Markets Debt Fund (MEDIX) and DoubleLine Emerging Markets Fixed Income Fund (DBLEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MEDIX	DBLEX	Difference
Sharpe ratio Return per unit of total volatility	3.25	3.23	+0.02
Sortino ratio Return per unit of downside risk	5.40	4.91	+0.50
Omega ratio Gain probability vs. loss probability	1.70	1.76	-0.06
Calmar ratio Return relative to maximum drawdown	3.09	3.68	-0.58
Martin ratio Return relative to average drawdown	13.52	15.00	-1.48
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MEDIX vs. DBLEX - Sharpe Ratio Comparison

The current MEDIX Sharpe Ratio is 3.25, which is comparable to the DBLEX Sharpe Ratio of 3.23. The chart below compares the historical Sharpe Ratios of MEDIX and DBLEX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	MEDIX	DBLEX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.25	3.23	+0.02
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.36	0.49	-0.12
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.64	0.83	-0.20
Sharpe Ratio (All Time) Calculated using the full available price history	0.98	1.01	-0.03

Drawdowns

MEDIX vs. DBLEX - Drawdown Comparison

The maximum MEDIX drawdown since its inception was -35.31%, which is greater than DBLEX's maximum drawdown of -25.43%. Use the drawdown chart below to compare losses from any high point for MEDIX and DBLEX.

Drawdown Indicators

	MEDIX	DBLEX	Difference
Max Drawdown Largest peak-to-trough decline	-35.31%	-25.43%	-9.88%
Max Drawdown (1Y) Largest decline over 1 year	-4.12%	-1.81%	-2.31%
Max Drawdown (3Y) Largest decline over 3 years	-7.48%	-4.54%	-2.94%
Max Drawdown (5Y) Largest decline over 5 years	-27.40%	-25.43%	-1.97%
Max Drawdown (10Y) Largest decline over 10 years	-27.40%	-25.43%	-1.97%
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	-4.44%	-3.49%	-0.95%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.94%	0.44%	+0.50%

Volatility

MEDIX vs. DBLEX - Volatility Comparison

MFS Emerging Markets Debt Fund (MEDIX) has a higher volatility of 1.39% compared to DoubleLine Emerging Markets Fixed Income Fund (DBLEX) at 0.74%. This indicates that MEDIX's price experiences larger fluctuations and is considered to be riskier than DBLEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MEDIX	DBLEX	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.39%	0.74%	+0.65%
Volatility (6M) Calculated over the trailing 6-month period	3.22%	1.54%	+1.68%
Volatility (1Y) Calculated over the trailing 1-year period	3.92%	2.06%	+1.86%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	5.89%	4.52%	+1.37%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	5.87%	4.65%	+1.22%

MEDIX vs. DBLEX - Expense Ratio Comparison

MEDIX has a 0.81% expense ratio, which is lower than DBLEX's 0.90% expense ratio.

Dividends

MEDIX vs. DBLEX - Dividend Comparison

MEDIX's dividend yield for the trailing twelve months is around 5.04%, less than DBLEX's 5.58% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
DBLEX DoubleLine Emerging Markets Fixed Income Fund	5.58%	5.59%	5.97%	5.54%	4.77%	4.00%	4.37%	4.57%	3.83%	4.33%	4.54%	5.21%
MEDIX MFS Emerging Markets Debt Fund	5.04%	5.22%	5.68%	4.90%	5.51%	4.33%	4.07%	4.59%	4.87%	4.46%	4.86%	5.25%

Frequently Asked Questions

Can I hold both MEDIX and DBLEX in my portfolio?

MEDIX and DBLEX have a correlation of 0.65, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, MEDIX or DBLEX?

MEDIX has higher volatility (1.39%) compared to DBLEX (0.74%). In terms of maximum drawdown, MEDIX dropped -35.31% vs DBLEX's -25.43%.

Which has better risk-adjusted returns?

MEDIX currently has the higher Sharpe Ratio (3.25 vs 3.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.